RE: Wow .. nearly all the buys from yesterday now selling off21 Feb 2023 11:26
HH Agreed. I am awaiting news as per your list you predicted last week. Fingers crossed as that is a lot of updates we are waiting for :
RE: Plenty in the Pipeline14 Feb '23
Updates from the #HEMO that we may see this year - I've added what my confidence level is for an update in 3mth to 6 mths (only my Opinion,,,)/
Anything I have missed ?
Are your confidence levels similar to mine?
1. IND Submission - confirming final step on pivotal transition to Clinical Biotech (99%)
2. Commencement of Human Trials (90%)
3. Confirmation of 1st Patient selected and dosed (90%)
4. Within 6-8 weeks, of dosing, initial findings of first patient - Tolerance and Efficacy (80%)
5. Details on #Hemo plans in Bioefense market (50%)
6. Multi-million dollar Biodefense grant (30%)
7. Further details on CBR proof of concept and next steps (80%)
8. TR1 - unveil new major or strategic shareholdings (50%)
9. Update on partnership for CBR - #Hemo already suggested they could work with multiple partners to take CBR
forwards on multiple fronts. (30%)
10. More details from #Hemo in regards to how the £4m recently raised will help them accelerate CAR-T and CBR drug candidates (80%)
11. Unveil plans to dual list and attract additional investment on NasDaq (20%)
12. Announce Investor day and/or Investor call + Vlad interviews (maybe with other leaders too?) (60%)
13. Announce receipt of offer from Big Pharma (Take over) - 10%
14. CDX Update (70%)
15, CBR fast tracked by FDA to cope with Covid (5%)